A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
- Status
- UNKNOWN
- Phase
- N/A
Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Haploidentical NK Cell Infusion in Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2
- Status
- COMPLETED
- Phase
- PHASE1
Multicentric Cohort of Melanoma Patients in Ile de France Area
- Status
- COMPLETED
- Phase
- N/A
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
- Status
- COMPLETED
- Phase
- PHASE2
Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
- Status
- COMPLETED
- Phase
- PHASE1
The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)
- Status
- COMPLETED
- Phase
- PHASE2
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Comparison of Video-Based Versus Written Patient Education on Melanoma
- Status
- COMPLETED
- Phase
- NA
Exploratory Study of Natural Killer Cells in Human Skin
- Status
- COMPLETED
- Phase
- NA
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
- Status
- COMPLETED
- Phase
- PHASE2
Tailored Intervention for Melanoma Patient's Families
- Status
- COMPLETED
- Phase
- NA
Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
- Status
- TERMINATED
- Phase
- PHASE3